SEC Form 4 · accession 0001140361-15-044135
PROVECTUS BIOPHARMACEUTICALS, INC. · PVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter R Culpepper
Officer — CFO & COO
Period of report
Dec 9, 2015
Accepted (ET)
Dec 10, 2015 · 1:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000315545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 9, 2015 | M | 138,831 | $0.94 | A | 1,251,163 | D | |
| Common Stock | Dec 9, 2015 | M | 6,383 | $0.94 | A | 190,503 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.75 | Dec 9, 2015 | A | 400,000 | A | Dec 9, 2015 | Dec 9, 2025 | Common Stock | 400,000 | 400,000 | D |
| Stock Option (right to buy)F1 | $0.94 | Dec 9, 2015 | M | 145,214 | D | Dec 9, 2006 | Dec 9, 2015 | Common Stock | 145,214 | 0 | D |
Explanation of responses
- F1The option, representing a right to purchase a total of 175,000 shares, became exercisable in three equal installments beginning on December 9, 2006, which was the first anniversary of the date on which the option was granted.